"more emphasis on Anti Virals to treat people once they have caught the flu, as opposed to trying to vaccinate their populations"
Quite right. In addition, a little appreciated but invaluable characteristic of Relenza is its prophylactic capabilities. A potential flu victim who has been exposed to someone exhibiting typical symptoms of flu can begin a course of Relenza and substantially reduce their risk of infection or at least of substantially reducing symptoms. Same with LANI. And - not only H1N1 swine flu but plethora of other flu variants. Try that with a vaccine!! - No Way!!
Intelligent use of effective antivirals is much more likely to prevent an epidemic of influenza than any known vaccination program.
The acceptnce of anti-virals as a front-line defence against influenza is hindered by ineffective competetitors (Tammiflu et al) and similarly ineffective technology (vaccines) - we battle the Suppression of the Unthinkable - the solution is right under our noses.
BTA Price at posting:
$2.01 Sentiment: Buy Disclosure: Held